Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01409590
What this trial is testing

Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications

Who this might be right for
Schizophrenia
Sheba Medical Center 100
Testing effectiveness (Phase 2)UnknownNCT05964790
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 112
Post-approval studies (Phase 4)Study completedNCT00761605
What this trial is testing

Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants

Who this might be right for
Schizophrenia
Janssen Korea, Ltd., Korea 387
Post-approval studies (Phase 4)Study completedNCT00682448
What this trial is testing

Metformin for the Prevention of the Metabolic Side-effects of Zyprexa

Who this might be right for
Metabolic Complications
Rush University Medical Center 25
Post-approval studies (Phase 4)UnknownNCT01962402
What this trial is testing

Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study

Who this might be right for
Weight Gain
Southern California Institute for Research and Education 15
Large-scale testing (Phase 3)Study completedNCT00215241
What this trial is testing

Risperidone Augmentation for PTSD

Who this might be right for
Post-Traumatic Stress Disorder
Duke University 80
Early research (Phase 1)Study completedNCT01556763
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderCentral Nervous System Diseases
FORUM Pharmaceuticals Inc 21
Post-approval studies (Phase 4)Study completedNCT00334035
What this trial is testing

Antipsychotic Therapy and First Episode

Who this might be right for
Schizophrenia
The University of Hong Kong 169
Not applicableActive Not RecruitingNCT06357195
What this trial is testing

DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients

Who this might be right for
Emergency PsychiatricCognition DisorderMovement Disorders+5 more
Ohio State University 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Large-scale testing (Phase 3)Study completedNCT01143077
What this trial is testing

A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sumitomo Pharma America, Inc. 244
Not applicableWithdrawnNCT00233467
What this trial is testing

Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

Who this might be right for
PTSDPosttraumatic Stress Disorder
Tuscaloosa Research & Education Advancement Corporation
Post-approval studies (Phase 4)Ended earlyNCT00508157
What this trial is testing

Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome

Who this might be right for
Metabolic SyndromeSchizophrenia
Bristol-Myers Squibb 125
Post-approval studies (Phase 4)Not Yet RecruitingNCT06590298
What this trial is testing

Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females

Who this might be right for
PsychosisMetabolic SyndromeWeight Gain
Universiti Putra Malaysia 600
Large-scale testing (Phase 3)UnknownNCT01280305
What this trial is testing

Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheba Medical Center 200
Large-scale testing (Phase 3)Study completedNCT00649844
What this trial is testing

A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 147
Not applicableStudy completedNCT01587521
What this trial is testing

Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia

Who this might be right for
Metabolic SyndromeQuality of LifeDepression
Chiang Mai University 80
Not applicableStudy completedNCT00222807
What this trial is testing

Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus

Who this might be right for
SchizophreniaSchizoaffective DisorderDelusional Disorder
University of Pittsburgh 200
Not applicableStudy completedNCT01222494
What this trial is testing

Healthy Bodies, Healthy Kids

Who this might be right for
Child Mental DisordersObesityMetabolic Syndrome
Washington University School of Medicine 47
Not applicableUnknownNCT01831986
What this trial is testing

Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sha'ar Menashe Mental Health Center 60
Next Page